{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:42:33Z","timestamp":1775202153992,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00415-013-7067-z","type":"journal-article","created":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T01:47:18Z","timestamp":1377913638000},"page":"2865-2875","source":"Crossref","is-referenced-by-count":7,"title":["Perioperative substitution of anti-epileptic drugs"],"prefix":"10.1007","volume":"260","author":[{"given":"Wilma S. W.","family":"Wichards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred F. A. M.","family":"Schobben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans S. S.","family":"Leijten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,1]]},"reference":[{"key":"7067_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/14656566.1.1.49","volume":"1","author":"JW Wheless","year":"1999","unstructured":"Wheless JW, Venkataraman V (1999) New formulations of drugs in epilepsy. Expert Opin Pharmacother 1:49\u201360","journal-title":"Expert Opin Pharmacother"},{"key":"7067_CR2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1528-1167.2009.02463.x","volume":"51","author":"G Krauss","year":"2010","unstructured":"Krauss G, Ben-Menachem E, Mameniskiene R, Vaiciene-Magistris N, Brock M, Whitesides JG, Johnson ME (2010) Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. Epilepsia 51:951\u2013957","journal-title":"Epilepsia"},{"key":"7067_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00006565-198806000-00006","volume":"4","author":"RC Woody","year":"1988","unstructured":"Woody RC, Laney SM (1988) Rectal anticonvulsants in pediatric practice. Pediatr Emerg Care 4:112\u2013116","journal-title":"Pediatr Emerg Care"},{"key":"7067_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00007691-200402000-00007","volume":"26","author":"DN Bailey","year":"2004","unstructured":"Bailey DN, Briggs JR (2004) The effect of parenteral nutrition fluids on the binding of therapeutic drugs to human serum in vitro. Ther Drug Monit 26:31\u201334","journal-title":"Ther Drug Monit"},{"key":"7067_CR5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0025-7125(05)70367-9","volume":"85","author":"NO Spell 3rd","year":"2001","unstructured":"Spell NO 3rd (2001) Stopping and restarting medications in the perioperative period. Med Clin North Am 85:1117\u20131118","journal-title":"Med Clin North Am"},{"key":"7067_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00002826-199710000-00008","volume":"5","author":"AL Rabinowicz","year":"1997","unstructured":"Rabinowicz AL, Salvat JM, Leiguarda RC, Demonty F, Salvat F, Cervio A, Manes F, Lazarowski A (1997) Use of antiepileptic drugs in nontraumatic neurosurgical procedures. Is there any best route and time of administration? Clin Neuropharmacol 5:438\u2013441","journal-title":"Clin Neuropharmacol"},{"key":"7067_CR7","volume-title":"Antiepileptic drugs: a clinician\u2019s manual","author":"AA Asadi-Pooya","year":"2009","unstructured":"Asadi-Pooya AA, Sperling MR (2009) Antiepileptic drugs: a clinician\u2019s manual. Oxford university press, New York"},{"key":"7067_CR8","volume-title":"Antiepileptic drugs","author":"RH Levy","year":"2002","unstructured":"Levy RH, Richard HM, Meldrum BS, Perucca E (2002) Antiepileptic drugs, 5th edn. Lippincott Williams en Wilkins, Philadelphia USA","edition":"5"},{"key":"7067_CR9","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1528-1167.2008.01618_3.x","volume":"49","author":"SG Uijl","year":"2008","unstructured":"Uijl SG, Moons KG, Leijten FS, Veltman EP, Budde A, van Donselaar CA (2008) Is epilepsy surgery utilized to its full extent? Epilepsia 49:1480\u20131481","journal-title":"Epilepsia"},{"key":"7067_CR10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/CCO.0b013e3283305996","volume":"21","author":"H Duffau","year":"2009","unstructured":"Duffau H (2009) Surgery of low-grade gliomas: towards a \u2018functional neurooncology\u2019. Curr Opin Oncol 21:543\u2013549","journal-title":"Curr Opin Oncol"},{"key":"7067_CR11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.annemergmed.2003.10.011","volume":"43","author":"MI Rudis","year":"2004","unstructured":"Rudis MI, Touchette DR, Swadron SP, Chiu AP, Orlinsky M (2004) Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department. Ann Emerg Med 43:386\u2013397","journal-title":"Ann Emerg Med"},{"key":"7067_CR12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/978-3-642-85921-2_22","volume-title":"Clinical pharmacology of anti-epileptic drugs","author":"JWA Meijer","year":"1975","unstructured":"Meijer JWA, Kalff R (1975) Less usual ways of administering anti-epileptic drugs. In: Schneider H, Janz D, Gardner-Thorpe C et al (eds) Clinical pharmacology of anti-epileptic drugs. Springer Verlag, Berlin, pp 222\u2013227"},{"key":"7067_CR13","unstructured":"Johannessen SI, Hendriksen O, Munthe-Kaas AW, Salvesen B (1984) Serum concentration profile studies of tablets and suppositories of valproate and carbamazepine in healthy subjects and patients with epilepsy. In: Johannessen SI, Morselli PL, Pippenger CE et al (eds) Metabolism of antiepileptic drugs. Raven Press, New York, pp 61\u201371"},{"key":"7067_CR14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1528-1157.1985.tb05675.x","volume":"26","author":"NM Graves","year":"1985","unstructured":"Graves NM, Kriel RL, Jones-Saete C, Cloyd JC (1985) Relative bioavailability of rectally administered carbamazepine suspension in humans. Epilepsia 26:429\u2013433","journal-title":"Epilepsia"},{"key":"7067_CR15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2125.1987.tb03258.x","volume":"24","author":"PJ Neuvonen","year":"1987","unstructured":"Neuvonen PJ, Tokola O (1987) Bioavailability of rectally administered carbamazepine mixture. Br J Clin Pharmacol 24:839\u2013841","journal-title":"Br J Clin Pharmacol"},{"key":"7067_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000069089","volume":"49","author":"C Crevoisier","year":"2003","unstructured":"Crevoisier C, Delisle MC, Joseph I, Foletti G (2003) Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers. Eur Neurol 49:173\u2013177","journal-title":"Eur Neurol"},{"key":"7067_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2125.1990.tb03616.x","volume":"29","author":"JD Wildin","year":"1990","unstructured":"Wildin JD, Pleuvry BJ, Mawer GE, Onon T, Millington L (1990) Respiratory and sedative effects of clobazam and clonazepam in volunteers. Br J Clin Pharmacol 29:169\u2013177","journal-title":"Br J Clin Pharmacol"},{"key":"7067_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","volume":"118","author":"J Riss","year":"2008","unstructured":"Riss J, Cloyd J, Gates J, Collins S (2008) Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 118:69\u201386","journal-title":"Acta Neurol Scand"},{"key":"7067_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.1982.tb01397.x","volume":"13","author":"S Dhillon","year":"1982","unstructured":"Dhillon S, Oxley J, Richens A (1982) Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients. Br J Clin Pharmacol 13:427\u2013432","journal-title":"Br J Clin Pharmacol"},{"key":"7067_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/j.1552-4604.1978.tb01605.x","volume":"18","author":"J Mendels","year":"1978","unstructured":"Mendels J, Secunda S, Schless A, Sandler K, Singer J (1978) A double-blind comparison of clobazam and diazepam in the treatment of anxiety neurosis. J Clin Pharmacol 18:353\u2013357","journal-title":"J Clin Pharmacol"},{"key":"7067_CR21","unstructured":"WINAp (2010) Informatorium Medicamentorum http:\/\/www.artsennet.nl\/Richtlijnen\/Per-organisatie\/KNMP-WINap.htm . Accessed January 2011"},{"key":"7067_CR22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/adc.61.2.186","volume":"61","author":"GW Rylance","year":"1986","unstructured":"Rylance GW, Poulton J, Cherry RC, Cullen RE (1986) Plasma concentrations of clonazepam after single rectal administration. Arch Dis Child 61:186\u2013188","journal-title":"Arch Dis Child"},{"key":"7067_CR23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0404.1983.tb04852.x","volume":"68","author":"P Klosterskov Jensen","year":"1983","unstructured":"Klosterskov Jensen P, Abild K, Nohr Poulsen M (1983) Serum concentration of clonazepam after rectal administration. Acta Neurol Scand 68:417\u2013420","journal-title":"Acta Neurol Scand"},{"key":"7067_CR24","unstructured":"Anonymous (2005) Gabapentin iv. injection iowa drug information service 9:64, USA"},{"key":"7067_CR25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1517\/17425250902997975","volume":"5","author":"K Eriksson","year":"2009","unstructured":"Eriksson K, Keranen T, Kalviainen R (2009) Fosphenytoin. Expert Opin Drug Metab Toxicol 5:695\u2013701","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"7067_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s13318-012-0093-x","volume":"37","author":"W Cawello","year":"2012","unstructured":"Cawello W, Boekens H, Bonn R (2012) Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration. Eur J Drug Metab Pharmacokinet 37:241\u2013248","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"7067_CR27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1592\/phco.21.2.158.34104","volume":"21","author":"AK Birnbaum","year":"2001","unstructured":"Birnbaum AK, Kriel RL, Im Y, Remmel RP (2001) Relative bioavailability of lamotrigine chewable dispersible tablets administered rectally. Pharmacotherapy 21:158\u2013162","journal-title":"Pharmacotherapy"},{"key":"7067_CR28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1528-1157.2000.tb00252.x","volume":"41","author":"AK Birnbaum","year":"2000","unstructured":"Birnbaum AK, Kriel RL, Burkhardt RT, Remmel RP (2000) Rectal absorption of lamotrigine compressed tablets. Epilepsia 41:850\u2013853","journal-title":"Epilepsia"},{"key":"7067_CR29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.clinthera.2006.05.004","volume":"28","author":"S Ramael","year":"2006","unstructured":"Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A (2006) Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther 28:734\u2013744","journal-title":"Clin Ther"},{"key":"7067_CR30","volume-title":"Farmacotherapeutisch kompas","author":"vAC Loenen","year":"2010","unstructured":"Loenen vAC, Sitsen JMA (2010) Farmacotherapeutisch kompas. College voor zorgverzekeringen, Amstelveen"},{"key":"7067_CR31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1592\/phco.31.10.934","volume":"31","author":"DD Spencer","year":"2011","unstructured":"Spencer DD, Jacobi J, Juenke JM, Fleck JD, Kays MB (2011) Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients. Pharmacotherapy 31:934\u2013941","journal-title":"Pharmacotherapy"},{"key":"7067_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/bmt.2008.91","volume":"42","author":"D Caselli","year":"2008","unstructured":"Caselli D, Ziino O, Bartoli A, Santangelo G, Vanadia F, Arico M (2008) Continuous intravenous infusion of lorazepam as seizure prophylaxis in children treated with high-dose busulfan. Bone Marrow Transplant 42:135\u2013136","journal-title":"Bone Marrow Transplant"},{"key":"7067_CR33","first-page":"173","volume":"76","author":"A Waltregny","year":"1976","unstructured":"Waltregny A, Dargent J (1976) Preliminary report: parenteral Lorazepam in induced epileptic states in man. Acta Neurol Belg 76:173\u2013179","journal-title":"Acta Neurol Belg"},{"key":"7067_CR34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1208\/s12249-008-9131-z","volume":"9","author":"AA Kale","year":"2008","unstructured":"Kale AA, Patravale VB (2008) Development and evaluation of lorazepam microemulsions for parenteral delivery. AAPS PharmSciTech 9:966\u2013971","journal-title":"AAPS PharmSciTech"},{"key":"7067_CR35","volume-title":"Handbook on injectable drugs","author":"LA Trissel","year":"2001","unstructured":"Trissel LA (2001) Handbook on injectable drugs, 11th edn. ASHP, Bethesda","edition":"11"},{"key":"7067_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1552-4604.1978.tb02448.x","volume":"18","author":"JT Conner","year":"1978","unstructured":"Conner JT, Katz RL, Bellville JW, Graham C, Pagano R, Dorey F (1978) Diazepam and lorazepam for intravenous surgical premedication. J Clin Pharmacol 18:285\u2013292","journal-title":"J Clin Pharmacol"},{"key":"7067_CR37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.1998.00781.x","volume":"46","author":"R Schwagmeier","year":"1998","unstructured":"Schwagmeier R, Alincic S, Striebel HW (1998) Midazolam pharmacokinetics following intravenous and buccal administration. Br J Clin Pharmacol 46:203\u2013206","journal-title":"Br J Clin Pharmacol"},{"key":"7067_CR38","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.clinthera.2011.10.012","volume":"33","author":"NM Veldhorst-Janssen","year":"2011","unstructured":"Veldhorst-Janssen NM, Fiddelers AA, van der Kuy PH, Theunissen HM, de Krom MC, Neef C, Marcus MA (2011) Pharmacokinetics and tolerability of nasal versus intravenous midazolam in healthy Dutch volunteers: a single-dose, randomized-sequence, open-label, 2-period crossover pilot study. Clin Ther 33:2022\u20132028","journal-title":"Clin Ther"},{"key":"7067_CR39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000542-198611000-00019","volume":"65","author":"C Saint-Maurice","year":"1986","unstructured":"Saint-Maurice C, Meistelman C, Rey E, Esteve C, de Lauture D, Olive G (1986) The pharmacokinetics of rectal midazolam for premedication in children. Anesthesiology 65:536\u2013538","journal-title":"Anesthesiology"},{"key":"7067_CR40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/BF02724074","volume":"72","author":"I Shah","year":"2005","unstructured":"Shah I, Deshmukh CT (2005) Intramuscular midazolam vs intravenous diazepam for acute seizures. Indian J Pediatr 72:667\u2013670","journal-title":"Indian J Pediatr"},{"key":"7067_CR41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2125.2008.03239.x","volume":"66","author":"SN Muchohi","year":"2008","unstructured":"Muchohi SN, Kokwaro GO, Ogutu BR, Edwards G, Ward SA, Newton CR (2008) Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions. Br J Clin Pharmacol 66:529\u2013538","journal-title":"Br J Clin Pharmacol"},{"key":"7067_CR42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01059259","volume":"10","author":"R Jochemsen","year":"1982","unstructured":"Jochemsen R, Hogendoorn JJ, Dingemanse J, Hermans J, Boeijinga JK, Breimer DD (1982) Pharmacokinetics and bioavailability of intravenous, oral, and rectal nitrazepam in humans. J Pharmacokinet Biopharm 10:231\u2013245","journal-title":"J Pharmacokinet Biopharm"},{"key":"7067_CR43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.seizure.2003.08.006","volume":"13","author":"F Albani","year":"2004","unstructured":"Albani F, Grassi B, Ferrara R, Turrini R, Baruzzi A, PRIMO Study Group (2004) Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. Seizure 13:254\u2013263","journal-title":"Seizure"},{"key":"7067_CR44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/088307389501000209","volume":"10","author":"J Arvidsson","year":"1995","unstructured":"Arvidsson J, Nilsson HL, Sandstedt P, Steinwall G, Tonnby B, Flesch G (1995) Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy. J Child Neurol 10:114\u2013117","journal-title":"J Child Neurol"},{"key":"7067_CR45","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1600-0404.2003.00234.x","volume":"109","author":"B Clemens","year":"2004","unstructured":"Clemens B, Menes A, Nagy Z (2004) Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine. Acta Neurol Scand 109:324\u2013329","journal-title":"Acta Neurol Scand"},{"key":"7067_CR46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-5173(79)90057-7","volume":"4","author":"F Moolenaar","year":"1979","unstructured":"Moolenaar F, Koning B, Huizinga T (1979) Biopharmaceutics of rectal administration of drugs in man 7. absorption rate and bioavailability of phenobarbital and its sodium salt from rectal dosage forms. Int J Pharmaceutics 4:99\u2013109","journal-title":"Int J Pharmaceutics"},{"key":"7067_CR47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1060028089023007-806","volume":"23","author":"NM Graves","year":"1989","unstructured":"Graves NM, Holmes GB, Kriel RL, Jones-Saete C, Ong B, Ehresman DJ (1989) Relative bioavailability of rectally administered phenobarbital sodium parenteral solution. DICP 23:565\u2013568","journal-title":"DICP"},{"key":"7067_CR48","first-page":"257","volume":"40","author":"E Minkov","year":"1985","unstructured":"Minkov E, Lambov N, Kirchev D, Bantutova I, Tencheva J (1985) Biopharmaceutical investigation of rectal suppositories. Part 2(1): pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium. Pharmazie 40:257\u2013259","journal-title":"Pharmazie"},{"key":"7067_CR49","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.46.6_Suppl_1.8S","volume":"46","author":"RH Mattson","year":"1996","unstructured":"Mattson RH (1996) Parenteral antiepileptic\/anticonvulsant drugs. Neurology 46:S8\u2013S13","journal-title":"Neurology"},{"key":"7067_CR50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/j.1552-4604.1978.tb02428.x","volume":"18","author":"CT Viswanathan","year":"1978","unstructured":"Viswanathan CT, Booker HE, Welling PG (1978) Bioavailability of oral and intramuscular phenobarbital. J Clin Pharmacol 18:100\u2013105","journal-title":"J Clin Pharmacol"},{"key":"7067_CR51","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1001\/archinte.159.22.2639","volume":"159","author":"PD Meek","year":"1999","unstructured":"Meek PD, Davis SN, Collins DM, Gidal BE, Rutecki PA, Burstein AH, Fischer JH, Leppik IE, Ramsay RE (1999) Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on nonemergency use of parenteral phenytoin products. Arch Intern Med 159:2639\u20132644","journal-title":"Arch Intern Med"},{"key":"7067_CR52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0920-1211(03)00083-4","volume":"54","author":"JM Conway","year":"2003","unstructured":"Conway JM, Birnbaum AK, Kriel RL, Cloyd JC (2003) Relative bioavailability of topiramate administered rectally. Epilepsy Res 54:91\u201396","journal-title":"Epilepsy Res"},{"key":"7067_CR53","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/epi.12134","volume":"54","author":"AM Clark","year":"2013","unstructured":"Clark AM, Kriel RL, Leppik IE, Marino SE, Mishra U, Brundage RC, Cloyd JC (2013) Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers. Epilepsia 54:1099\u20131105","journal-title":"Epilepsia"},{"key":"7067_CR54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00625806","volume":"17","author":"F Moolenaar","year":"1980","unstructured":"Moolenaar F, Greving WJ, Huizinga T (1980) Absorption rate and bioavailability of valproic acid and its sodium from rectal dosage forms. Eur J Clin Pharmacol 17:309\u2013315","journal-title":"Eur J Clin Pharmacol"},{"key":"7067_CR55","volume-title":"Formularium der Nederlandse Apothekers","author":"FNA","year":"1997","unstructured":"FNA (1997) Formularium der Nederlandse Apothekers. WINAp, Den Haag"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7067-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7067-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7067-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T18:22:34Z","timestamp":1563819754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7067-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["7067"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7067-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,1]]}}}